Group One Trading
TMCI icon

Group One Trading’s Treace Medical Concepts TMCI Stock Holding History

Group One Trading’s Portfolio TMCI Stock Details TMCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-400
Closed -$2.68K – 9160
2025
Q3 		$2.68K Buy
400
+300
+300% +$1.96K ﹤0.01% 7812
2025
Q2 		$588 Sell
100
-2,400
-96% -$15.6K ﹤0.01% 7637
2025
Q1 		$21K Sell
2,500
-106,500
-98% -$957K ﹤0.01% 5791
2024
Q4 		$811K Buy
109,000
+67,500
+163% +$452K ﹤0.01% 2759
2024
Q3 		$241K Buy
41,500
+26,500
+177% +$170K ﹤0.01% 3452
2024
Q2 		$99.8K Buy
15,000
+14,200
+1,775% +$115K ﹤0.01% 3961
2024
Q1 		$10.4K Buy
+800
New +$10.7K ﹤0.01% 5842
2023
Q4 		– Sell
-20,000
Closed -$262K – 8196
2023
Q3 		$262K Hold
20,000
– – ﹤0.01% 3570
2023
Q2 		$512K Sell
20,000
-57,000
-74% -$1.47M ﹤0.01% 2989
2023
Q1 		$1.94M Sell
77,000
-26,900
-26% -$632K 0.01% 1557
2022
Q4 		$2.39M Buy
103,900
+7,400
+8% +$170K 0.01% 1674
2022
Q3 		$2.13M Buy
96,500
+88,800
+1,153% +$1.72M ﹤0.01% 1862
2022
Q2 		$110K Sell
7,700
-32,000
-81% -$539K ﹤0.01% 4904
2022
Q1 		$751K Buy
+39,700
New +$772K ﹤0.01% 3387

Other funds holding TMCI

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GA
Gagnon Advisors New York $157M AUM 36.77% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
CBU
CIBC Bancorp USA Chicago, Illinois $82.3B AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Group One Trading's TMCI Position: Q2 2026 in Review

Group One Trading increased its Treace Medical Concepts (TMCI) stake by 155% in Q2 2026, buying an estimated $25.3K and bringing the position to 15,147 shares worth $60.3K. The position accounts for ﹤0.01% of the portfolio, ranked #5254.

Group One Trading first reported a position in TMCI in Q4 2023 and has held it in 9 quarters since. The position peaked at $1.61M in Q4 2023. 116 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Group One Trading held 15,147 shares of Treace Medical Concepts worth $60.3K as of Q2 2026.
  • Group One Trading bought 9,208 Treace Medical Concepts shares in Q2 2026, an estimated $25.3K.
  • Treace Medical Concepts made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #5254 holding.
  • Group One Trading first reported a position in Treace Medical Concepts in Q4 2023 and has held it in 9 quarters since.
  • Group One Trading's Treace Medical Concepts position peaked at $1.61M in Q4 2023.
  • 116 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.